Adult Growth Hormone Deficiency

Search Trials
A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency
Status:
Completed
Last Changed:
Jul 9, 2020
First Changed:
Mar 9, 2015
Disease(s):
Adult Growth Hormone Deficiency
Intervention(s):
somapacitansomatropin
Diagnosing Adult Growth Hormone Deficiency
Status:
Completed
Last Changed:
Jan 12, 2017
First Changed:
Jan 12, 2017
Disease(s):
Growth Hormone Deficiency
Intervention(s):
GHRH plus arginine test
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
Status:
Terminated
Last Changed:
Mar 8, 2018
First Changed:
Mar 25, 2016
Disease(s):
Adult Growth Hormone Deficiency (AGHD)
Intervention(s):
somavaratan
Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety
Status:
Completed
Last Changed:
Dec 13, 2006
First Changed:
Mar 1, 2006
Disease(s):
Adult Growth Hormone Deficiency
Intervention(s):
ALTU-238
MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)
Status:
Completed
Last Changed:
Oct 8, 2019
First Changed:
Oct 21, 2010
Disease(s):
Adult Growth Hormone Deficiency
Intervention(s):
MOD-4023MOD-4023MOD-4023MOD-4023

Connect. Empower. Inspire.